| Drug product |
Flour prepared from the food, administered in a food vehicle |
Liquid extract prepared from the food source |
| Typical daily maintenance dose |
300–4000 mg |
2–7 mg |
| Common side effects |
Oral, gastrointestinal |
Oropharyngeal |
| Severe side effects |
Anaphylaxis; development of eosinophilic esophagitis |
Systemic reactions are exceedingly rare |
| Desensitization |
Vast majority of subjects completing the protocol |
Can increase the threshold for reactions, but not as robust as OIT |
| Sustained unresponsiveness (tolerance) |
Achieved in some subjects; may depend on length of dosing period |
Unknown |
